Company / Book Value per Share
Gilead Sciences Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$18.221
FY2025
5-year range
$15.514 / $18.31
FY2021-FY2025
Trend
+17.4%
vs FY2024
Sector context
#33 of 209
Health Care
What the data says
Gilead Sciences's book value per share of $18.221 is higher than 84% of companies in the Health Care sector (FY2025). Book Value per Share has fluctuated over the past 10 years, ranging from $13.282 in FY2016 to $18.31 in FY2023.
Based on SEC 10-K filings.
$18.221 in FY2025 with a 5-year CAGR of +4.9%. Top quartile in the Health Care sector.
Remained stable around $18.221 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +2.5%
- 5-Year CAGR
- +4.9%
- 10-Year CAGR
- -
Sector benchmark
-90.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.9%, indicating consistent growth.
- In FY2025, book value per share increased 17.4% year-over-year.
- Ranks #33 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2023.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.221 | +17.4% |
| FY2024 | $15.514 | -15.3% |
| FY2023 | $18.31 | +8.1% |
| FY2022 | $16.938 | +0.8% |
| FY2021 | $16.801 | +16.9% |
| FY2020 | $14.378 | -18.2% |
| FY2019 | $17.57 | +7.5% |
| FY2018 | $16.351 | +4.8% |
| FY2017 | $15.605 | +17.5% |
| FY2016 | $13.282 | +7.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026